Unknown

Dataset Information

0

A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.


ABSTRACT: Many preclinical experiments have attested to the critical role of CD4(+) T cell help in CD8(+) cytotoxic T lymphocyte (CTL)-mediated immunity. Recent clinical trials have demonstrated that reinfusion of CD4(+) T cells can induce responses in infectious diseases and cancer. However, few standardized and versatile systems exist to expand antigen-specific CD4(+) T(h) for clinical use. K562 is a human erythroleukemic cell line, which lacks expression of HLA class I and class II, invariant chain and HLA-DM but expresses adhesion molecules such as intercellular adhesion molecule-1 and leukocyte function-associated antigen-3. With this unique immunologic phenotype, K562 has been tested in clinical trials of cancer immunotherapy. Previously, we created a K562-based artificial antigen-presenting cell (aAPC) that generates ex vivo long-lived HLA-A2-restricted CD8(+) CTL with a central/effector memory phenotype armed with potent effector function. We successfully generated a clinical version of this aAPC and conducted a clinical trial where large numbers of anti-tumor CTL are reinfused to cancer patients. In this article, we shifted focus to CD4(+) T cells and developed a panel of novel K562-derived aAPC, where each expresses a different single HLA-DR allele, invariant chain, HLA-DM, CD80, CD83 and CD64; takes up soluble protein by endocytosis and processes and presents CD4(+) T-cell peptides. Using this aAPC, we were able to determine novel DR-restricted CD4(+) T-cell epitopes and expand long-lived CD4(+) T-cells specific for multiple antigens without growing bystander Foxp3(+) regulatory T cells. Our results suggest that K562-based aAPC may serve as a translatable platform to generate both antigen-specific CD8(+) CTL and CD4(+) T(h).

SUBMITTER: Butler MO 

PROVIDER: S-EPMC2994545 | biostudies-other | 2010 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.

Butler Marcus O MO   Ansén Sascha S   Tanaka Makito M   Imataki Osamu O   Berezovskaya Alla A   Mooney Mary M MM   Metzler Genita G   Milstein Matthew I MI   Nadler Lee M LM   Hirano Naoto N  

International immunology 20101108 11


Many preclinical experiments have attested to the critical role of CD4(+) T cell help in CD8(+) cytotoxic T lymphocyte (CTL)-mediated immunity. Recent clinical trials have demonstrated that reinfusion of CD4(+) T cells can induce responses in infectious diseases and cancer. However, few standardized and versatile systems exist to expand antigen-specific CD4(+) T(h) for clinical use. K562 is a human erythroleukemic cell line, which lacks expression of HLA class I and class II, invariant chain and  ...[more]

Similar Datasets

| S-EPMC3079474 | biostudies-literature
| S-EPMC2192565 | biostudies-other
| S-EPMC9021956 | biostudies-literature
| S-EPMC4910811 | biostudies-literature
| S-EPMC4703746 | biostudies-literature
2022-05-31 | GSE183768 | GEO
| S-EPMC2828865 | biostudies-literature
| S-EPMC6028479 | biostudies-literature
| S-EPMC6773487 | biostudies-literature
| PRJEB21583 | ENA